Ciprofloxacin Kabi 400 mg/200 ml roztwór do infuzji

GIF decision: Withdrawal from market

What does this decision mean?

• Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.

It was found that Ciprofloxacin Kabi cartons contained bottles labeled Glucosum 5% Fresenius with the same batch number, indicating mix-up of infusion products and risk of administering the wrong medicine. Potential effects: lack of efficacy, infusion-related complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Ciprofloxacin Kabi 400 mg/200 ml roztwór do infuzji

Risk Level

Critical

Manufacturer

Fresenius Kabi Deutschland GmbH

Batch Number

15QFD570

Notice Date

10.09.2021

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

1

Do not eat or use the product

Stop using or consuming it immediately and keep it out of reach of children.
2

Check the batch number and expiry date

Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
3

Return it to the shop

You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
4

Get help and report it

If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Important Information

What You Should Know

Recommendations

Do not use the product from batch 15QFD570; healthcare facilities and pharmacies should immediately segregate this batch and return it to the wholesaler or the marketing authorisation holder.

Actions Taken

Withdrawal from the market throughout the country of batch 15QFD570 of the medicinal product Ciprofloxacin Kabi 400 mg/200 ml solution for infusion, granting the decision immediate enforceability, and...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

Ciprofloxacin Kabi 400 mg/200 ml roztwór do infuzji

What to do if you have this product?

What You Should Know

Recommendations

Actions Taken

Need Help?

Other Notices

Teicoplanin AptaPharma

Teicoplanin AptaPharma

Azaneson

Imuldosa

Loperamid APTEO MED